3-Year follow-up of tension-free vaginal tape—ABBREVO procedure for the treatment of pure urodynamic stress urinary incontinence: efficacy and adverse effects

Braga, Andrea; Caccia, Giorgio; Ruggeri, Giovanni; Regusci, Luca; Papadia, Andrea; Serati, Maurizio

doi:10.1007/s00192-019-04096-4

Cited by 6 publications

(10 citation statements)

References 30 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Another article in the IUJ this year showed that the mini-sling is an effective treatment for urodynamic stress incontinence after a 3-year follow-up, and the incidence of de novo overactive bladder was 4.9% and 15% at the 1-and 3-year follow-up, respectively. There were no serious late complications, and no tape revision or resection was required over 3 years [3].…”

mentioning

confidence: 92%

See 1 more Smart Citation

Can the mini-sling become the golden standard for treating stress urinary incontinence?

2020

View full text Add to dashboard Cite

mentioning

confidence: 92%

“…Mesh exposure following its use is important. In these two trials, rates of mesh exosure for the mini-sling were 2% and 4.9% in 3 years of follow-up, respectively [2,3]. Another 24month follow-up study showed 3.37% of mesh exposure was ≤ 1 cm, and 2.24% was > 1 cm according to the IUGA/ICS Classification of Prosthesis-related Complications [1].…”

mentioning

confidence: 97%

Can the mini-sling become the golden standard for treating stress urinary incontinence?

2020

View full text Add to dashboard Cite

“…Since their introduction [ 1 ], tension-free vaginal tape mid-urethral slings (Gynecare TVT System®) have been considered the most effective and safest procedure for the treatment of female stress urinary incontinence [ 2 – 4 ]. However, in recent years, the criticisms regarding the use of transvaginal mesh for pelvic organ prolapse (POP) repair have also involved the mesh intended for the treatment of SUI.…”

Section: Introductionmentioning

confidence: 99%

The subjective and objective very long-term outcomes of TVT in the COVID era: A 20-year follow-up

et al. 2022

Self Cite

View full text Add to dashboard Cite

Introduction and hypothesis Few studies in literature have assessed the long-term durability and mesh-related complications of mid-urethral slings (MUSs). The aim of this study is to assess the efficacy and safety of retro-pubic tension-free vaginal tape (TVT) 20 years after implantation for the treatment of female stress urinary incontinence (SUI). Methods A prospective observational study was conducted in two urogynaecologic units in two countries. All the patients involved were consecutive women with urodynamically proven pure SUI treated by TVT. The patients underwent preoperative clinical and urodynamic evaluations. Subjective outcomes, objective outcomes and adverse events were recorded during the follow-up period. Results Fifty-two patients underwent a TVT surgical procedure. Twenty years after surgery, 32 out of 36 patients (88.8%) declared themselves cured (p = 0.98). Similarly, 33 out of these 36 patients (91.7%) were objectively cured (p = 0.98). No significant deterioration of subjective and objective cure rates was observed over time (p for trend 0.50 and 0.48). Fifteen of the 36 patients (41.6%) at the 20-year follow-up reported the onset of de novo overactive bladder (OAB) (p = 0.004). No significant vaginal bladder or urethral erosion or de novo dyspareunia was recorded and no patient required tape release or resection during this period. The cause of death of seven out of ten women who died in the last year of the follow-up period was coronavirus disease 19 (COVID 19). Conclusions The 20-year results of this study showed that TVT is a highly effective and safe option for the treatment of SUI. The impact of COVID 19 on the mortality rate of elderly women has drastically reduced the number of eligible patients for future evaluations in our region.

show abstract

“…This is an update of our previous study [ 9 ]. We evaluated women who underwent TVT-A procedure at a follow-up of at least 5 years.…”

Section: Introductionmentioning

confidence: 63%

“…Nevertheless, a small number of studies in the literature analyzed the efficacy and safety of TVT-A in the medium- and long-term. We previously reported the 3-year subjective and objective results of women who underwent TVT-A implantation [ 9 ] and demonstrated that it was a highly effective and safe option for the treatment of female SUIs.…”

Section: Introductionmentioning

confidence: 99%

Medium Term Outcomes of TVT-Abbrevo for the Treatment of Stress Urinary Incontinence: Efficacy and Safety at 5-Year Follow-Up

et al. 2022

View full text Add to dashboard Cite

Background and objectives: Stress urinary incontinence (SUI) is the most common type of urinary incontinence, affecting approximately 46% of adult women. After failure of conservative treatment, the mid-urethral sling (MUS) is considered the most effective and safe surgical procedure for SUI. In 2012, Waltregny et al. introduced a new trans-obturator tension-free vaginal tape (TVT) procedure, named TVT-abbrevo (TVT-A). The aim of the present study is to evaluate the efficacy and safety of the TVT-A procedure in women with pure SUI at 5-year follow-up. Materials and Methods: All women who complained of pure SUI symptoms with concomitant urodynamic stress incontinence (USI) were prospectively enrolled and treated with the TVT-A procedure. Postoperative subjective outcome measures included: International Consultation on Incontinence Questionnaire–Short Form (ICI-Q SF), Patient Global Impression of Improvement (PGI-I) scale, and patient degree of satisfaction scale. A PGI-I score ≤2 and a patient-satisfaction score ≥8 were used to define subjective success. Objective success was defined as the absence of urine leakage during a cough stress test. Adverse events were collected according to the Clavien–Dindo classification during follow-up. Results: Univariable analysis was used to investigate outcomes. Fifty women who met the inclusion criteria underwent TVT-A implantation. At 5 years after TVT-A implantation, 38 out of 45 (84.4%) patients were subjectively cured (p for trend 0.05), and 40 out of 45 (88.9%) patients were objectively cured (p for trend 0.04). A significant trend of de novo OAB symptoms was reported (22.2% [10/45]) at the 5-year follow-up. No serious early or late complications such as urethral/bladder injury, persistent groin-thigh pain, and sexual dysfunction that required mesh removal were detected. The univariate analysis did not reveal any risk factors (i.e., age, body mass index (BMI), menopause, obstetric factors, and preoperative ICIQ- SF questionnaire) statistically associated with failure of the TVT-A procedure. Conclusions: In conclusion, the 5-year follow-up results of this study demonstrated that TVT-A is a safe and effective option for treatment of SUI with a very low rate of post-operative groin–thigh pain

show abstract

3-Year follow-up of tension-free vaginal tape—ABBREVO procedure for the treatment of pure urodynamic stress urinary incontinence: efficacy and adverse effects

Cited by 6 publications

References 30 publications

Can the mini-sling become the golden standard for treating stress urinary incontinence?

Can the mini-sling become the golden standard for treating stress urinary incontinence?

The subjective and objective very long-term outcomes of TVT in the COVID era: A 20-year follow-up

Medium Term Outcomes of TVT-Abbrevo for the Treatment of Stress Urinary Incontinence: Efficacy and Safety at 5-Year Follow-Up

Contact Info

Product

Resources

About